System and Method to Modulate Phrenic Nerve to Prevent Sleep Apnea
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 60/737,808, filed Nov 18, 2005. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,518,090 | System and Method to Modulate Phrenic Nerve to Prevent Sleep Apnea Term ended Term ended Nov 17, 2026 · High confidence UsedRemaining | Zoll Respicardia, Inc. | Term ended | Term ended Nov 17, 2026 | High confidence | |
| US 11,305,119 | System and Method to Modulate Phrenic Nerve to Prevent Sleep Apnea In force · High confidence | Zoll Respicardia, Inc. | In force | High confidence | ||
| US 12,616,839 | System and Method to Modulate Phrenic Nerve to Prevent Sleep Apnea In force · Medium confidence | Zoll Respicardia, Inc. | In force | Medium confidence | ||
| US 12,179,014 | Transvenous Phrenic Nerve Stimulation System In force · High confidence | Zoll Respicardia, Inc. | In force | High confidence | ||
| US 10,406,366 | Transvenous Phrenic Nerve Stimulation System In force · High confidence | Zoll Respicardia, Inc. | In force | High confidence | ||
| US 8,244,359 | System and Method to Modulate Phrenic Nerve to Prevent Sleep Apnea In force · High confidence | Zoll Respicardia, Inc. | In force | High confidence | ||
| Application 16/689,740 | System and Method to Modulate Phrenic Nerve to Prevent Sleep Apnea Abandoned Abandoned Jan 25, 2022 | Zoll Respicardia, Inc. | Abandoned | Abandoned Jan 25, 2022 | ||
| Application 18/957,241 | Transvenous Phrenic Nerve Stimulation System Pending Not granted | Zoll Respicardia, Inc. | Pending | Not granted |
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Zoll Respicardia, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.